EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Morin Attenuates Hyperglycemia and Metabolic Dysregulation in Ovariectomized Diabetic Mouse Model

Josué Vidal Espinosa-Juárez iD, Viridiana Orantes-Sánchez iD, Joaquín Gómez-Morga, Citlaly Natali de la Torre-Sosa iD, Alfredo Briones-Aranda, Osmar Antonio Jaramillo-Morales iD, Josselin Carolina Corzo-Gómez iD, Refugio Cruz-Trujillo iD, Raúl Cruz-Cadena iD, Raquel Gómez Pliego iD

Medical Sciences · 03.07.2026 · 14 (3) · 371

DOI: 10.3390/medsci14030371 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Sciences, online erschienen am 03.07.2026. Verfasst von Josué Vidal Espinosa-Juárez und 9 weiteren Autor:innen. Beteiligte Einrichtung: Escuela de Ciencias Químicas, Universidad Autónoma de Chiapas (UNACH), Carretera Panamericana Ocozocoautla-Cintalapa Km. 2.5, Ocozocoautla de Espinos…. Hauptthemen laut MEDLINE: Flavonoids, Hyperglycemia, Diabetes Mellitus, Experimental. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Estrogen deficiency is associated with metabolic disturbances and impaired glucose homeostasis. Morin, a natural flavonol, has shown promising hypoglycemic and antioxidant properties, but its effects under hypoestrogenic diabetic conditions remain poorly understood. The aim of this study was to evaluate the effects of morin on body weight, fasting blood glucose, glucose tolerance, and selected serum biochemical markers in an experimental model of diabetes under estrogen-deficient conditions (ovariectomized diabetic female mice).

Methods

Female CD1 mice underwent sham surgery or ovariectomy (OVX), and each surgical condition was further divided into non-diabetic and diabetic subgroups treated with vehicle, glibenclamide (10 mg/kg), or morin (30 mg/kg). Body weight and fasting blood glucose were monitored over a 15-day treatment period. Oral glucose tolerance was assessed on day 15, and serum biochemical markers, including glucose, cholesterol, triglycerides, uric acid, blood urea nitrogen, creatinine, ALT, and AST, were measured thereafter.

Results

Ovariectomy aggravated diabetes-associated hyperglycemia, impaired glucose tolerance, and triglyceride elevation. Morin treatment reduced fasting blood glucose and improved glucose tolerance in diabetic mice, including ovariectomized animals. Morin also attenuated the increase in serum triglycerides and blood urea nitrogen in ovariectomized diabetic mice, although it did not significantly improve cholesterol, uric acid, creatinine, ALT, or AST levels. Compared with glibenclamide, morin showed relevant glucose-lowering activity but had a more limited effect on the overall biochemical profile.

Conclusions

These findings suggest that morin may partially improve glycemic control and selected metabolic alterations in experimental diabetes associated with estrogen deficiency. Further studies are required to clarify its mechanisms of action, long-term efficacy, and translational relevance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlavonoidsHyperglycemiaDiabetes Mellitus, ExperimentalAnimalsFemaleOvariectomyFlavonesMiceBlood GlucoseDisease Models, AnimalBody WeightHypoglycemic AgentsGlucose Tolerance Test

Stichwörter der Autor:innen

diabetesflavonoidhypoestrogenismmorin

Substanzen

FlavonoidsmorinFlavonesBlood GlucoseHypoglycemic Agents

Autor:innen und Institutionen

  • Escuela de Ciencias Químicas, Universidad Autónoma de Chiapas (UNACH), Carretera Panamericana Ocozocoautla-Cintalapa Km. 2.5, Ocozocoautla de Espinosa 29140, Chiapas, Mexico.
  • Facultad de Medicina Humana Campus II, Universidad Autónoma de Chiapas (UNACH), Décima Sur Esquina Calle Central S/N, Tuxtla Gutiérrez 29050, Chiapas, Mexico.
  • Departamento de Enfermería y Obstetricia, División de Ciencias de la Vida, Campus Irapuato-Salamanca, Universidad de Guanajuato, Ex Hacienda el Copal, Km. 9 Carretera Irapuato-Silao, A.P. 311, Irapuato 36500, Guanajuato…
  • Departamento de Químicos Farmacobiólogos, Universidad Pablo Guardado Chávez (UPGCH), Libramiento Norte Oriente No. 3450, Tuxtla Gutiérrez 29040, Chiapas, Mexico.
  • Sección de Ciencias de la Salud Humana, Departamento de Ciencias Biológicas, Facultad de Estudios Superiores Cuautitlán, Universidad Nacional Autónoma de México, Cuautitlán Izcalli 54740, Estado de México, Mexico.

ORCID-Profile: Josué Vidal Espinosa-Juárez, Viridiana Orantes-Sánchez, Citlaly Natali de la Torre-Sosa, Osmar Antonio Jaramillo-Morales, Josselin Carolina Corzo-Gómez, Refugio Cruz-Trujillo, Raúl Cruz-Cadena, Raquel Gómez Pliego

Zitieren

APA

Espinosa-Juárez, J. V., Orantes-Sánchez, V., Gómez-Morga, J., de la Torre-Sosa, C. N., Briones-Aranda, A., Jaramillo-Morales, O. A., Corzo-Gómez, J. C., Cruz-Trujillo, R., Cruz-Cadena, R., & Gómez Pliego, R. (2026). Morin Attenuates Hyperglycemia and Metabolic Dysregulation in Ovariectomized Diabetic Mouse Model. Medical Sciences, 14(3), 371. https://doi.org/10.3390/medsci14030371

Vancouver

Espinosa-Juárez JV, Orantes-Sánchez V, Gómez-Morga J, de la Torre-Sosa CN, Briones-Aranda A, Jaramillo-Morales OA, et al. Morin Attenuates Hyperglycemia and Metabolic Dysregulation in Ovariectomized Diabetic Mouse Model. Medical Sciences. 2026;14(3):371. doi:10.3390/medsci14030371

BibTeX
@article{EspinosaJurez2026,
  author = {Espinosa-Juárez, Josué Vidal and Orantes-Sánchez, Viridiana and Gómez-Morga, Joaquín and de la Torre-Sosa, Citlaly Natali and Briones-Aranda, Alfredo and Jaramillo-Morales, Osmar Antonio and Corzo-Gómez, Josselin Carolina and Cruz-Trujillo, Refugio and Cruz-Cadena, Raúl and Gómez Pliego, Raquel},
  title = {Morin Attenuates Hyperglycemia and Metabolic Dysregulation in Ovariectomized Diabetic Mouse Model},
  journal = {Medical Sciences},
  year = {2026},
  volume = {14},
  number = {3},
  pages = {371},
  doi = {10.3390/medsci14030371}
}
Kostenlos starten →